Clinical outcomes and quality of life in patients with acute and subacute type B aortic dissection after thoracic endovascular aortic repair

Abstract

Objective Thoracic endovascular aortic repair (TEVAR) is considered the mini-invasive treatment of choice for patients with Stanford type B aortic dissection (TBAD). This study aimed to investigate the clinical outcomes and quality of life (QoL) in patients with acute and subacute TBAD after TEVAR. Methods From January 2014 until July 2016, 22 acute patients (Group A) and 18 subacute patients received TEVAR (Group B), and 13 patients were managed non-operatively (Group C). The Medical Outcomes Study Short Form-36 was used to assess QoL preoperatively and after TEVAR. Operative techniques and complications were retrospectively analyzed. Results The role emotion, vitality, and mental health domains scored well preoperatively. Except for role emotion, vitality, and mental health, the remaining domains significantly improved after TEVAR. There was no significant difference in QoL metrics between Groups A and B. In Group C, bodily pain and social functioning domains were improved, and role emotion was decreased, with no improvement in the remaining domains. The 3-year survival rates were 95.5%, 100%, and 85.7% for Groups A, B, and C, respectively. Conclusions TEVAR may be safe and effective in patients with acute and subacute TBAD with similar and favorable clinical and QoL metrics.

Mid- and long-term outcomes of thoracic endovascular aortic repair in acute and subacute uncomplicated type B aortic dissection

“…The overall survival rates for acute un-TBAD at 1 year and 3 years were reported (96.8%±3.1% and 90.4%±9.5%, respectively). Bi et al [11] also published overall survival rates at 3-year post-TEVAR and found 95.5% for acute (<15 days) and 100% for subacute (15-92 days) TBAD. The study included a total of 53 acute and subacute TBAD patients randomized into 3 groups (22 acute TBAD + TEVAR; 18 subacute TBAD + TEVAR; 13 TBAD + non-operative treatment).…”

“…Mid-and long-term outcomes of thoracic endovascular aortic repair in acute and subacute uncomplicated type B aortic dissection Matti Jubouri 1 *, Mohammed Al-Tawil 2 *, Ho Cheung Anthony Yip 3 , Ali Bashir 4 , Sven ZCP Tan 5 , Mohamad Bashir MD PhD MRCS 6 , Richard Anderson BSc MBBS MD 7 , Damian Bailey PhD FRSC FPVRI FACSM FTPS 8 , Christoph A. Nienaber MD PhD MRCP 9 , Joseph S. Coselli MD 10,11,12 , Ian Williams MD FRCS 13…”

Mid‐ and long‐term outcomes of thoracic endovascular aortic repair in acute and subacute uncomplicated type B aortic dissection

“…The overall survival rates for acute un‐TBAD at 1 and 3 years were reported (96.8 ± 3.1% and 90.4 ± 9.5%, respectively). Bi et al 11 also published overall survival rates at 3‐year post‐TEVAR and found 95.5% for acute (<15 days) and 100% for subacute (15–92 days) TBAD. The study included a total of 53 acute and subacute TBAD patients randomized into three groups (22 acute TBAD + TEVAR; 18 subacute TBAD + TEVAR; 13 TBAD + nonoperative treatment).…”

Correlation between health promotion behavior and quality of life in survivors of stanford B aortic dissection

“…The SF-36 questionnaire has been widely used to evaluate the quality of life after thoracic aortic surgery [14,15] , including patients with acute Type A AD after aortic replacement [16] , patients with AD after TEVAR [17] and patients with abdominal aortic aneurysm repair [18] . Therefore, the questionnaire is practical and applicable to the study population.…”